LENSAR to Present at Two Upcoming Investor Conferences
February 08 2021 - 8:00AM
Business Wire
LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a
global medical technology company focused on advanced femtosecond
laser surgical solutions for the treatment of cataracts, today
announced that Nick Curtis, Chief Executive Officer, will present
at two upcoming investor conferences:
BTIG Virtual MedTech, Digital Health, Life Science &
Diagnostic Tools Conference Thursday, February 18, 2021 at 4:00
p.m. Eastern Time
SVB Leerink 10th Annual Global Healthcare Conference
Thursday, February 25, 2021 at 3:40 p.m. Eastern Time
Live webcasts of the presentations can be accessed through the
Investors section of the Company's website at
https://ir.lensar.com. A replay of the webcasts will be available
on the LENSAR website for two weeks following the respective
conferences.
About LENSAR
LENSAR is a commercial-stage medical device company focused on
designing, developing and marketing an advanced femtosecond laser
system for the treatment of cataracts and the management of
pre-existing or surgically induced corneal astigmatism. Its LENSAR
Laser System incorporates a range of proprietary technologies
designed to assist the surgeon in obtaining better visual outcomes,
efficiency and reproducibility by providing advanced imaging,
simplified procedure planning, efficient design and precision.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210208005181/en/
Thomas R. Staab, II, CFO ir.contact@lensar.com
Lee Roth / Cameron Radinovic Burns McClellan for LENSAR
lroth@burnsmc.com / cradinovic@burnsmc.com
LENSAR (NASDAQ:LNSR)
Historical Stock Chart
From Sep 2024 to Oct 2024
LENSAR (NASDAQ:LNSR)
Historical Stock Chart
From Oct 2023 to Oct 2024